118:
22:
63:
219:
to late-stage development. QP encourages more transparent and objective study designs, as well as more data-driven risk-taking to optimize timelines, analyses, and decision-making, resulting in greater efficiency in the drug development process.
342:
Barrett, JS; Shi, J; Xie, HT; Huang, XH; Fossler, MJ; Sun, RY (Jul 2008). "Globalization of quantitative pharmacology: first international symposium of quantitative pharmacology in drug development and regulation".
215:, and individual variability into improved patient outcomes by leveraging improved teamwork and collaboration to enable quantitative decision-making processes from
546:
Zhang, L; Sinha, V; Forgue, ST; Callies, S; Ni, L; Peck, R; Allerheiligen, SR (Jun 2006). "Model-based drug development: the road to quantitative pharmacology".
592:
35:
460:
Putnam, WS; Li, J; Haggstrom, J; Ng, C; Kadkhodayan-Fischer, S; Cheu, M; Deniz, Y; Lowman, H; Fielder, P; Visich, J; Joshi, A; Jumbe, NS (Jun 2008).
262:
Atkinson, AJ Jr; Lalonde, RL (Jul 2007). "Introduction of quantitative methods in pharmacology and clinical pharmacology: a historical overview".
139:
81:
179:
161:
99:
49:
380:
Holford, N; Karlsson, MO (Jul 2007). "Time for quantitative clinical pharmacology: a proposal for a pharmacometrics curriculum".
41:
132:
126:
199:(QSP), is an organized approach integrating individuals from different disciplines in a combined effort to develop
143:
462:"Use of quantitative pharmacology in the development of HAE1, a high-affinity anti-IgE monoclonal antibody"
200:
571:
448:
405:
368:
287:
563:
534:
491:
440:
397:
360:
330:
279:
237:
555:
524:
516:
481:
473:
430:
389:
352:
320:
312:
271:
204:
301:"The role of quantitative pharmacology in an academic translational research environment"
529:
505:"Concepts and Challenges in Quantitative Pharmacology and Model-Based Drug Development"
504:
486:
461:
325:
300:
216:
586:
575:
452:
409:
372:
291:
212:
559:
520:
477:
316:
435:
418:
356:
393:
275:
567:
538:
495:
444:
401:
364:
334:
283:
208:
419:"Quantitative clinical pharmacology: Making paradigm shifts a reality"
72:
provides insufficient context for those unfamiliar with the subject
203:
in order to solve specific, complex, and multivariate problems in
111:
56:
15:
77:
8:
207:. QP translates the relationship(s) between
50:Learn how and when to remove these messages
528:
503:Zhang, L; Pfister, M; Meibohm, B (2008).
485:
434:
324:
180:Learn how and when to remove this message
162:Learn how and when to remove this message
100:Learn how and when to remove this message
125:This article includes a list of general
229:
82:providing more context for the reader
7:
593:Mathematical and theoretical biology
238:"Quantitative Systems Pharmacology"
131:it lacks sufficient corresponding
14:
197:Quantitative Systems Pharmacology
31:This article has multiple issues.
244:. Cambridge Healthtech Institute
116:
61:
20:
39:or discuss these issues on the
1:
548:J Pharmacokinet Pharmacodyn
609:
560:10.1007/s10928-006-9010-8
521:10.1208/s12248-008-9062-3
478:10.1208/s12248-008-9045-4
317:10.1208/s12248-007-9002-7
193:Quantitative Pharmacology
436:10.1177/0091270006292978
357:10.1177/0091270008319331
417:Krishna, R (Sep 2006).
394:10.1038/sj.clpt.6100231
276:10.1038/sj.clpt.6100248
146:more precise citations.
299:Barrett, JS (2008).
382:Clin Pharmacol Ther
264:Clin Pharmacol Ther
242:Discovery on Target
201:quantitative models
78:improve the article
190:
189:
182:
172:
171:
164:
110:
109:
102:
54:
600:
579:
542:
532:
499:
489:
456:
438:
423:J Clin Pharmacol
413:
376:
345:J Clin Pharmacol
338:
328:
295:
254:
253:
251:
249:
234:
205:drug development
185:
178:
167:
160:
156:
153:
147:
142:this article by
133:inline citations
120:
119:
112:
105:
98:
94:
91:
85:
65:
64:
57:
46:
24:
23:
16:
608:
607:
603:
602:
601:
599:
598:
597:
583:
582:
545:
502:
459:
416:
379:
341:
298:
261:
258:
257:
247:
245:
236:
235:
231:
226:
217:early discovery
186:
175:
174:
173:
168:
157:
151:
148:
138:Please help to
137:
121:
117:
106:
95:
89:
86:
75:
66:
62:
25:
21:
12:
11:
5:
606:
604:
596:
595:
585:
584:
581:
580:
543:
500:
457:
414:
377:
339:
296:
256:
255:
228:
227:
225:
222:
188:
187:
170:
169:
124:
122:
115:
108:
107:
69:
67:
60:
55:
29:
28:
26:
19:
13:
10:
9:
6:
4:
3:
2:
605:
594:
591:
590:
588:
577:
573:
569:
565:
561:
557:
554:(3): 369–93.
553:
549:
544:
540:
536:
531:
526:
522:
518:
514:
510:
506:
501:
497:
493:
488:
483:
479:
475:
472:(2): 425–30.
471:
467:
463:
458:
454:
450:
446:
442:
437:
432:
428:
424:
420:
415:
411:
407:
403:
399:
395:
391:
387:
383:
378:
374:
370:
366:
362:
358:
354:
351:(7): 787–92.
350:
346:
340:
336:
332:
327:
322:
318:
314:
310:
306:
302:
297:
293:
289:
285:
281:
277:
273:
269:
265:
260:
259:
243:
239:
233:
230:
223:
221:
218:
214:
210:
206:
202:
198:
194:
184:
181:
166:
163:
155:
145:
141:
135:
134:
128:
123:
114:
113:
104:
101:
93:
83:
79:
73:
70:This article
68:
59:
58:
53:
51:
44:
43:
38:
37:
32:
27:
18:
17:
551:
547:
515:(4): 552–9.
512:
508:
469:
465:
429:(9): 966–7.
426:
422:
388:(1): 103–5.
385:
381:
348:
344:
308:
304:
267:
263:
246:. Retrieved
241:
232:
196:
192:
191:
176:
158:
149:
130:
96:
87:
76:Please help
71:
47:
40:
34:
33:Please help
30:
311:(1): 9–14.
248:12 November
213:drug action
144:introducing
270:(1): 3–6.
224:References
152:April 2018
127:references
36:improve it
195:(QP), or
90:June 2020
42:talk page
587:Category
576:25246940
568:16770528
539:19003542
496:18686041
453:31443478
445:16920890
410:41815609
402:17495873
373:21049234
365:18490494
335:18446501
292:32337361
284:17571065
530:2628212
487:2751395
326:2751447
209:disease
140:improve
574:
566:
537:
527:
509:AAPS J
494:
484:
466:AAPS J
451:
443:
408:
400:
371:
363:
333:
323:
305:AAPS J
290:
282:
129:, but
572:S2CID
449:S2CID
406:S2CID
369:S2CID
288:S2CID
564:PMID
535:PMID
492:PMID
441:PMID
398:PMID
361:PMID
331:PMID
280:PMID
250:2015
556:doi
525:PMC
517:doi
482:PMC
474:doi
431:doi
390:doi
353:doi
321:PMC
313:doi
272:doi
80:by
589::
570:.
562:.
552:33
550:.
533:.
523:.
513:10
511:.
507:.
490:.
480:.
470:10
468:.
464:.
447:.
439:.
427:46
425:.
421:.
404:.
396:.
386:82
384:.
367:.
359:.
349:48
347:.
329:.
319:.
309:10
307:.
303:.
286:.
278:.
268:82
266:.
240:.
211:,
45:.
578:.
558::
541:.
519::
498:.
476::
455:.
433::
412:.
392::
375:.
355::
337:.
315::
294:.
274::
252:.
183:)
177:(
165:)
159:(
154:)
150:(
136:.
103:)
97:(
92:)
88:(
84:.
74:.
52:)
48:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.